Trulieve Cannabis Corp. 10-Q Summary: Q3 2025
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2025. Trulieve Cannabis Corp. is a vertically integrated multi-state cannabis operator with retail and cultivation facilities in nine U.S. states. As of the reporting date, the company operated 232 dispensaries and 15 cultivation/processing facilities. The company is a large accelerated filer and reports in U.S. dollars.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|---|
| Revenue | $288.2 million | $284.3 million | $888.0 million | $885.3 million |
| Gross Profit | $169.9 million | $173.3 million | $536.0 million | $528.7 million |
| Gross Margin | 58.9% | 61.0% | 60.4% | 59.7% |
| Operating Income | $42.2 million | $0.6 million | $128.2 million | $96.5 million |
| Net Loss (GAAP) | $(28.8) million | $(61.9) million | $(78.7) million | $(99.0) million |
| Adjusted EBITDA | $102.7 million | $96.1 million | $322.5 million | $308.8 million |
| Cash & Equivalents | $449.2 million | $237.7 million | $449.2 million | $237.7 million |
| Operating Cash Flow (YTD) | $213.6 million | $240.8 million | $213.6 million | $240.8 million |
| Total Debt (Long-Term) | $609.1 million | $638.3 million | $609.1 million | $638.3 million |
Note: Total Debt includes Private Placement Notes ($366.1M), Notes Payable ($107.7M), and Construction Finance Liabilities ($134.3M) as of Sept 30, 2025.
Material Changes vs. Prior Period
- Revenue Growth: Q3 revenue increased 1.4% year-over-year, driven by new store openings, adult-use sales in Ohio, and wholesale growth, partially offset by price compression.
- Expense Reduction: Selling, General, and Administrative (SG&A) expenses decreased significantly by 33% in Q3 ($99.0M vs $148.6M) and 10% YTD. This was primarily due to a reduction in campaign and political contributions ($6.3M in Q3 2025 vs $48.4M in Q3 2024).
- Profitability: Operating income improved dramatically to $42.2M in Q3 2025 from $0.6M in Q3 2024. Net loss narrowed by 53% in Q3 and 21% YTD.
- Liquidity: Cash and cash equivalents increased to $449.2M from $238.8M at year-end 2024, supported by strong operating cash flows.
- Tax Liability: Uncertain tax position liabilities increased to $616.3M (from $445.2M at year-end 2024), driven by interest accruals on tax positions challenging IRC Section 280E.
Guidance, Outlook, and Risks
- Subsequent Event: On November 4, 2025, the company issued a notice to redeem all outstanding $368.0 million of its 8% 2026 Notes on December 5, 2025.
- Tax Contingencies: The IRS issued Revenue Agent Reports in September 2025 proposing assessments of taxes, interest, and penalties. While tax and interest amounts are accrued, a proposed penalty of approximately $38.1 million is not included in liabilities as the company intends to contest it vigorously.
- Lease Guarantee: A $6.5 million liability was recorded in Q2 2025 due to a tenant default on a terminated cultivation lease where Trulieve is secondarily liable.
- Outlook: Management expects existing cash balances to meet requirements for the next 12 months. The company continues to invest in infrastructure, technology, and market expansion, particularly in adult-use markets.
- Risks: Key risks include federal illegality of cannabis, potential asset forfeiture, intense competition, and the outcome of ongoing IRS audits regarding IRC Section 280E.
Investor Verification Checklist
- Debt Redemption: Verify the execution and funding of the $368M note redemption scheduled for December 5, 2025.
- Tax Position: Monitor the status of the IRS audit and the $38.1M proposed penalty not currently accrued.
- Price Compression: Assess the impact of ongoing price compression on gross margins in key markets like Florida and Arizona.
- Political Contributions: Confirm the sustainability of reduced SG&A expenses given the historical volatility of campaign spending.
- Lease Liability: Track the resolution of the $6.5M lease guarantee liability.